Barclays
OFIX icon

Barclays’s Orthofix Medical OFIX Stock Holding History

Barclays’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,000
Closed -$262K – 7233
2018
Q4 		$262K Buy
+5,000
New +$284K ﹤0.01% 4382
2014
Q2 		– Sell
-65,000
Closed -$1.95M – 7747
2014
Q1 		$1.95M Buy
+65,000
New +$1.5M ﹤0.01% 2577

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Barclays's OFIX Position: Q2 2026 in Review

Barclays reduced its Orthofix Medical (OFIX) stake by 15% in Q2 2026, selling an estimated $57.6K and leaving 30,760 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #3527.

Barclays first reported a position in OFIX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.4M in Q2 2013. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Barclays held 30,760 shares of Orthofix Medical worth $281K as of Q2 2026.
  • Barclays sold 5,227 Orthofix Medical shares in Q2 2026, an estimated $57.6K.
  • Orthofix Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3527 holding.
  • Barclays first reported a position in Orthofix Medical in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Orthofix Medical position peaked at $3.4M in Q2 2013.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.